Selective Serotonin Reuptake Inhibitors (SSRIs): Overview ofregulatory status and CSM advice relating to major depressive disorder (MDD) inchildren and adolescents including a summary of available safety and efficacydata
British government (MHRA) summary of safety and efficacy data for SSRIs in major depressive disorder in children and adolescents.
Hits to Selective Serotonin Reuptake Inhibitors (SSRIs): Overview ofregulatory status and CSM advice relating to major depressive disorder (MDD) inchildren and adolescents including a summary of available safety and efficacydata:
0
| Rating:
0
| Votes:
0
